NLRP3 and diabetes mellitus: In general DM, this often presents as non-alcoholic fatty liver disease (NAFLD), defined by excessive hepatic fat accumulation, oxidative stress, and chronic inflammation mediated by cytokines and the NLRP3 inflammasome, potentially progressing to fibrosis and cirrhosis.